RYTNX
Price
$449.88
Change
-$7.28 (-1.59%)
Updated
Jul 13 closing price
Net Assets
229.77M
RYVLX
Price
$849.48
Change
-$33.39 (-3.78%)
Updated
Jul 13 closing price
Net Assets
1.44B
Interact to see
Advertisement

RYTNX vs RYVLX

RYTNX vs RYVLX Comparison Chart in %
View a ticker or compare two or three
VS
RYTNX vs. RYVLX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYTNX is a Buy and RYVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.44B vs. RYTNX (230M). RYTNX (0.00) and RYVLX (0.00) have matching dividends . RYTNX was incepted earlier than RYVLX: RYTNX (26 years) vs RYVLX (22 years). RYVLX (1.87) and RYTNX (1.84) have similar cost to investors . RYTNX is a more actively managed with annual turnover of: 1197.00 vs. RYVLX (383.00). RYTNX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 46.56 vs. RYTNX (31.47). RYVLX return over 5 years is better than : 104.75 vs. RYTNX (94.59).
RYTNXRYVLXRYTNX / RYVLX
Total Expense Ratio1.741.74100%
Annual Report Gross Expense Ratio1.841.8798%
Fund Existence26 years22 years-
Gain YTD18.56732.73857%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets230M1.44B16%
Annual Yield % from dividends0.000.00-
Returns for 1 year31.4746.5668%
Returns for 3 years108.52142.2776%
Returns for 5 years94.59104.7590%
Returns for 10 years514.511063.2948%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CAMX34.84N/A
N/A
Cambiar Aggressive Value ETF
RUNN33.05N/A
N/A
Running Oak Efficient Growth ETF
JAJL29.96-0.06
-0.20%
Innovator Eq Dfnd Prot ETF - 6Mo Jan/Jul
TAGG42.08-0.15
-0.36%
T. Rowe Price QM US Bond ETF
MSSM59.96-0.54
-0.89%
Morgan Stanley Pathway Sm-Md Cp Eq ETF